FY2027 1Q revenue was ¥10,439 million, down 4.8% year on year, while the company posted an operating loss of ¥214 million. The full-year forecasts of ¥48,500 million in revenue and ¥1,000 million in operating profit were maintained. In FY2027 H1, the focus will be the extent of the recovery from the loss and whether momentum can be rebuilt to meet the full-year forecasts.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-25 〜 2026-11-07 · 8 of 8 items
Scroll the timeline →
Will cumulative 2Q revenue reach the ¥48,500 million full-year forecast, corresponding to the simple 50% benchmark for H1?
Will cumulative 2Q operating income (loss) recover to ¥0 million or higher?
Can the remaining full-year operating profit target of ¥1,214 million at the end of 1Q be built up from 2Q onward?
Will the full-year forecasts of ¥48,500 million in revenue and ¥1,000 million in operating profit be maintained or revised?
FY2027 1Q revenue was ¥10,439 million, down 4.8% from ¥10,964 million in the year-earlier quarter. Operating income (loss) swung from a ¥391 million profit in the year-earlier quarter to a ¥214 million loss, while the operating margin fell by approximately 5.6 percentage points, from approximately 3.6% to approximately negative 2.1%. Profit deterioration was significantly greater than the decline in revenue, making changes in profitability, rather than revenue scale alone, the central issue for the next earnings release.
1Q revenue represented approximately 21.5% of the full-year forecast, calculated as ¥10,439 million divided by ¥48,500 million. This was approximately 3.5 percentage points below the 25% benchmark based on a simple assumption of equal quarterly contributions. Operating income (loss) was a ¥214 million loss, so progress on the earnings side was even slower. To meet the company’s forecast mechanically, the remaining period after 1Q would need to generate ¥38,061 million in revenue and ¥1,214 million in operating profit, although the seasonal assumptions and quarterly breakdown required for H1 have not been disclosed.
The company indicated that sales volumes of processed foods and meat, feed for juvenile yellowtail, and feed for overseas markets declined as a result of prioritizing profitability. On the earnings side, it explicitly cited margin deterioration caused by higher raw material prices for compound feed. However, it did not disclose the extent of the decline in sales volumes, the impact of higher raw material costs, or the amount absorbed through price revisions. The disclosure therefore does not allow the ¥214 million 1Q operating loss to be broken down into volume, price, and cost factors.
For the next earnings release, covering FY2027 H1, the minimum checkpoint will be whether cumulative 2Q operating income (loss) recovers to ¥0 million or higher. It will also be necessary to check whether the year-on-year decline in revenue improves, whether the operating margin returns to positive territory, and whether the company provides specific assumptions for raw material prices and sales volumes if it maintains its full-year forecast. No earnings forecast revision was made as of 1Q, so any additional explanation supporting the continued numerical targets will be important.
¥ million
Revenue declined by only 4.8%, but operating income swung from a profit to a loss, with the drop in earnings substantially exceeding the change in revenue.
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-11-13 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-11-14 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
22,369JPY m
↘ -9.4% YoYOperating profitCore earnings
787JPY m
↗ +299.5% YoYNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 10,439↘ -4.8% YoY | 45,586↘ -7.5% YoY | 35,619↘ -10.2% YoY | 22,369↘ -9.4% YoY | 10,964YoY unavailable | 49,267YoY unavailable | 39,645YoY unavailable | 24,677YoY unavailable |
| Operating profit | -214↘ -154.7% YoY | 1,316↗ +22.3% YoY | 1,596↗ +56.5% YoY | 787↗ +299.5% YoY | 391YoY unavailable | 1,076YoY unavailable | 1,020YoY unavailable | 197YoY unavailable |
| Ordinary profit | -98↘ -118.6% YoY | 1,673↗ +22.7% YoY | 1,851↗ +45.2% YoY | 969↗ +164.0% YoY | 526YoY unavailable | 1,363YoY unavailable | 1,275YoY unavailable | 367YoY unavailable |
| Net income | -54↘ -114.8% YoY | 1,275↗ +20.9% YoY | 1,347↗ +37.7% YoY | 735↗ +205.0% YoY | 364YoY unavailable | 1,055YoY unavailable | 978YoY unavailable | 241YoY unavailable |
| Earnings per share | -6.62↘ -115.4% YoY | 153.7↗ +24.5% YoY | 161.67↗ +41.8% YoY | 87.49↗ +212.2% YoY | 43.09YoY unavailable | 123.42YoY unavailable | 114.04YoY unavailable | 28.02YoY unavailable |